Tuvalu vs Uruguay: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Tuvalu
97.0%
in 2025
Uruguay
97.0%
in 2025
Tuvalu rank
17th
Uruguay rank
17th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Tuvalu
- Uruguay
How they compare
Tuvalu currently reports 97.0% against 97.0% in Uruguay, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Uruguay ahead.
Tuvalu ranks 17th and Uruguay ranks 17th of 194 countries.
Uruguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Tuvalu | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 93.4% | 93.4% | Uruguay |
| 2020s | 62.5% | 94.8% | 32.3% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Tuvalu or Uruguay?
- Tuvalu, at 97.0% against 97.0% in Uruguay as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Tuvalu and Uruguay?
- 0.0%, with Tuvalu ahead.
- How many years of comparable data are there for Tuvalu and Uruguay?
- 18 years are reported by both, from 2008 to 2025.
- How do Tuvalu and Uruguay rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Tuvalu ranks 17th and Uruguay ranks 17th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.